Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Neurology · Lobar and Semilobar Holoprosencephaly

What is the Prognosis for Lobar and Semilobar HPE?

At a Glance

Children with lobar and semilobar holoprosencephaly (HPE) often survive into adolescence and adulthood. While they typically face developmental delays, seizures, and hormone imbalances, early interventions like physical and speech therapy help maximize their comfort and individual potential.

When a child is diagnosed with lobar or semilobar holoprosencephaly (HPE), it is natural to wonder what their future will look like. While the most severe form (alobar HPE) is often life-limiting early on, children with lobar (the mildest form) and semilobar (the intermediate form) HPE have a much more favorable prognosis. Many individuals with these milder subtypes survive well into their teens and adulthood [1][2]. Their long-term outlook and daily life depend heavily on the specific structure of their brain and whether they have other associated health conditions [3][4].

What to Expect: Development and Milestones

Developmental outcomes in non-alobar HPE are highly variable, meaning no two children will have the exact same abilities [1]. However, almost all children with these diagnoses will experience some degree of developmental delay [4][5].

  • Lobar HPE: Because the brain hemispheres are mostly separated, some children with lobar HPE may eventually learn to walk and use verbal speech. However, they typically still face mild to severe intellectual disabilities and require ongoing support [6][7].
  • Semilobar HPE: Children with this intermediate form generally experience more profound delays. Many face significant motor impairments, such as spastic quadriplegia (severe muscle stiffness affecting all four limbs), and may rely on a wheelchair for mobility [8][9]. Communication abilities vary, with some children communicating primarily through sounds, expressions, or non-verbal communication devices rather than spoken words [8].

One of the most accurate predictors of a child’s future ability to sit or walk independently is the degree of thalamic fusion—how much the deep centers of the brain (the thalami) are joined together, which can be seen on an MRI [10][11]. Additionally, sensory evaluations for vision and hearing are essential, as midline brain defects can affect these systems and influence future learning and development.

Managing Day-to-Day Health Challenges

As your child grows, their medical care will focus on managing specific symptoms to maximize their comfort and capability. Common lifelong challenges include:

  • Seizures (Epilepsy): Seizures are very common across the HPE spectrum. These require ongoing monitoring by a neurologist and are typically managed with anti-seizure medications [4][12].
  • Hormone Imbalances: The brain’s hypothalamus and pituitary gland are often affected, leading to critical endocrine issues. This can include Central Diabetes Insipidus (CDI), which affects the body’s ability to balance water and salt [13][14]. Warning signs of CDI dehydration include excessive thirst (if they can communicate it), unusually large amounts of dilute urine, extreme lethargy, or a sunken soft spot on an infant’s head. Additionally, children can have adrenal insufficiency (cortisol deficiency), which requires careful monitoring by a pediatric endocrinologist because it can become a life-threatening emergency during acute illnesses [15][13].
  • Feeding and Swallowing: Many children struggle with swallowing safely. A gastroenterologist or speech therapist can help. Some children may need a feeding tube (G-tube) to ensure they get enough nutrition without the risk of fluid entering their lungs (aspiration) [12][16]. Warning signs of aspiration include coughing or choking during feeds, a “wet” sounding voice after eating, or frequent respiratory infections.
  • Movement Disorders: Muscle stiffness (spasticity) or involuntary movements (dystonia) can develop and may require medication or targeted therapies to keep the child comfortable [8][17].

The Role of Early and Proactive Intervention

Because the brain has a remarkable ability to adapt, especially in early childhood, early intervention is critical [18]. A multidisciplinary team of therapists will be a constant part of your child’s life:

  • Physical Therapy (PT): Essential for managing muscle stiffness, preventing joint contractures (permanently tight muscles or joints), and maximizing independent mobility, whether that means rolling, crawling, walking, or using a wheelchair [18].
  • Occupational Therapy (OT): Focuses on daily living skills, adapting the child’s environment, and improving fine motor control. OT also helps with finding the right adaptive equipment.
  • Speech Therapy (ST): Crucial for finding the best way for your child to communicate, whether through spoken words, sign language, or augmentative and alternative communication (AAC) devices. Speech therapists also play a vital role in assessing and managing swallowing difficulties [16].

With proactive, specialized medical care and dedicated therapy, children with lobar and semilobar HPE can continue to learn, communicate, and reach their individual maximum potential.

Common questions in this guide

Can children with lobar or semilobar holoprosencephaly survive into adulthood?
Yes, many individuals with lobar and semilobar HPE survive well into their teens and adulthood. Their specific long-term outlook depends on their individual brain structure and whether they have other associated health conditions.
Will a child with lobar HPE learn to walk and talk?
Development varies widely among children with lobar HPE. Because their brain hemispheres are mostly separated, some children do eventually learn to walk and use verbal speech, though most still face varying degrees of intellectual disability.
Why is thalamic fusion important in an HPE diagnosis?
The degree of thalamic fusion seen on an MRI shows how much the deep centers of the brain are joined together. This measurement is one of the most accurate predictors of a child's future ability to sit or walk independently.
What are the warning signs of Central Diabetes Insipidus in a child with HPE?
Central Diabetes Insipidus affects the body's ability to balance water and salt. Warning signs in children with HPE include unusually large amounts of dilute urine, extreme lethargy, excessive thirst, or a sunken soft spot on an infant's head.
How do doctors treat swallowing difficulties in children with HPE?
Speech therapists and gastroenterologists assess swallowing safety to prevent aspiration, where fluid enters the lungs. When swallowing is unsafe, doctors often place a feeding tube (G-tube) to ensure the child receives proper nutrition.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the extent of thalamic fusion on my child's MRI, and how should that guide our expectations for their motor development?
  2. 2.How soon can we get a referral to a pediatric endocrinologist to screen for Central Diabetes Insipidus and adrenal insufficiency?
  3. 3.What specific signs of silent aspiration should we be looking for at home during feedings?
  4. 4.What early intervention programs (Physical, Occupational, and Speech therapies) do you recommend we initiate immediately?
  5. 5.How often will my child need EEGs or neurological evaluations to monitor for the onset of seizures?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    In-depth investigations of adolescents and adults with holoprosencephaly identify unique characteristics.

    Weiss K, Kruszka P, Guillen Sacoto MJ, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2018; (20(1)):14-23 doi:10.1038/gim.2017.68.

    PMID: 28640243
  2. 2

    Lobar holoprosencephaly with associated meningocele: A rare case report of a 25-year-old patient with multiple seizures.

    Barman P, Mishra GV, Murugan G, et al.

    Radiology case reports 2025; (20(4)):2004-2008 doi:10.1016/j.radcr.2025.01.029.

    PMID: 39963386
  3. 3

    Semilobar Holoprosencephaly: Capacious Anomaly in the Cephalad.

    Veluchamy M, Murugan M

    Cureus 2020; (12(7)):e9181 doi:10.7759/cureus.9181.

    PMID: 32802616
  4. 4

    Developmental, Endocrine, and Ophthalmologic Outcomes in Children Prenatally Diagnosed With Midline Brain Malformations.

    Coletti ML, Keene JC, Smego AR, et al.

    Pediatric neurology 2025; (167()):82-88 doi:10.1016/j.pediatrneurol.2025.03.005.

    PMID: 40228397
  5. 5

    SEC31A mutation affects ER homeostasis, causing a neurological syndrome.

    Halperin D, Kadir R, Perez Y, et al.

    Journal of medical genetics 2019; (56(3)):139-148 doi:10.1136/jmedgenet-2018-105503.

    PMID: 30464055
  6. 6

    Holoprosencephaly: a survey of the entity, with embryology and fetal imaging.

    Winter TC, Kennedy AM, Woodward PJ

    Radiographics : a review publication of the Radiological Society of North America, Inc 2015; (35(1)):275-90 doi:10.1148/rg.351140040.

    PMID: 25590404
  7. 7

    Facial Evaluation in Holoprosencephaly.

    Pucciarelli V, Bertoli S, Codari M, et al.

    The Journal of craniofacial surgery 2017; (28(1)):e22-e28 doi:10.1097/SCS.0000000000003171.

    PMID: 27875510
  8. 8

    Nasal fistula, epidermal cyst and hypernatremia in a girl presenting holoprosencephaly due to a rare ZIC2 point mutation.

    de Almeida IG, Kuratani DK, Gomes LM, et al.

    European journal of medical genetics 2020; (63(2)):103641 doi:10.1016/j.ejmg.2019.03.005.

    PMID: 30894326
  9. 9

    Expanded Phenotype Associated With an Intronic PPP1R12A Variant: A Case Report and Literature Review.

    Bland EM, Weinstein AN, Kao EC, et al.

    American journal of medical genetics. Part A 2026; doi:10.1002/ajmg.a.70212.

    PMID: 42178607
  10. 10

    Are the prevalence of Trisomy 13 and the incidence of severe holoprosencephaly increasing in Africa?

    Okoye JO, Ngokere AA

    Prenatal diagnosis 2020; (40(12)):1616-1617 doi:10.1002/pd.5777.

    PMID: 32715507
  11. 11

    Prenatal diagnosis of holoprosencephaly.

    Kousa YA, du Plessis AJ, Vezina G

    American journal of medical genetics. Part C, Seminars in medical genetics 2018; (178(2)):206-213 doi:10.1002/ajmg.c.31618.

    PMID: 29770996
  12. 12

    Semilobar holoprosencephaly associated with maternal diabetes in a toddler: A case report.

    Çelik C, Mirre F, İbrahim İG

    Radiology case reports 2026; (21(8)):3448-3452 doi:10.1016/j.radcr.2026.04.065.

    PMID: 42253868
  13. 13

    Intravenous formulation of desmopressin delivered via oral and g tube routes for the treatment of central diabetes insipidus: First experience in infants.

    Lim WY, Riba-Wolman R

    Clinical endocrinology 2020; (92(2)):179-181 doi:10.1111/cen.14125.

    PMID: 31715009
  14. 14

    Sublingual Administration of Desmopressin Oral Disintegrating Tablet in a Neonate With Central Diabetes Insipidus.

    Watanabe D, Yagasaki H, Tsukahara M, et al.

    Cureus 2025; (17(7)):e87902 doi:10.7759/cureus.87902.

    PMID: 40809652
  15. 15

    CNOT1 p.Arg535Cys variant in holoprosencephaly with late onset diabetes mellitus.

    de Queiroz Júnior AF, Sanseverino MTV, Collares MVM, et al.

    American journal of medical genetics. Part A 2024; (194(12)):e63836 doi:10.1002/ajmg.a.63836.

    PMID: 39149840
  16. 16

    Holoprosencephaly: Review of Embryology, Clinical Phenotypes, Etiology and Management.

    Malta M, AlMutiri R, Martin CS, Srour M

    Children (Basel, Switzerland) 2023; (10(4)) doi:10.3390/children10040647.

    PMID: 37189898
  17. 17

    Holoprosencephaly-Associated Hyperkinesia.

    Dy ME, Chuang NA, Friedman J

    Movement disorders clinical practice 2015; (2(3)):310-312 doi:10.1002/mdc3.12176.

    PMID: 30363551
  18. 18

    Holoprosencephaly from conception to adulthood.

    Weiss K, Kruszka PS, Levey E, Muenke M

    American journal of medical genetics. Part C, Seminars in medical genetics 2018; (178(2)):122-127 doi:10.1002/ajmg.c.31624.

    PMID: 30182446

This page provides educational information on lobar and semilobar holoprosencephaly prognosis. It does not replace professional medical advice. Always consult your child's pediatric neurology and endocrinology team for personalized guidance.

Get notified when new evidence is published on Holoprosencephaly.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.